Friday, 10 November 2017

Dynavax stock surges 18% on hepatitis B vaccine approval https://t.co/pKwWGpsk6s


http://twitter.com/MarketWatch/status/928960982101184512
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)